Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To assess the clinical improvement (change in seizure frequency), safety and tolerability of patients with partial seizures following adjunctive therapy of pregabalin BID in addition to existing standard AEDs.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pregabalin | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Reduction in seizure frequency. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Bruges | 8000 | Belgium | |||
| Pfizer Investigational Site |
Not provided
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Brussels |
| B-1070 |
| Belgium |
| Pfizer Investigational Site | Duffel | 2570 | Belgium |
| Pfizer Investigational Site | Ghent | 9000 | Belgium |
| Pfizer Investigational Site | Leuven | 3000 | Belgium |
| Pfizer Investigational Site | Liège | B-4000 | Belgium |
| Pfizer Investigational Site | Tielt | 8700 | Belgium |
| Pfizer Investigational Site | Yvoir | 5530 | Belgium |
| Pfizer Investigational Site | Helsinki | 00250 | Finland |
| Pfizer Investigational Site | Kuopio | 70210 | Finland |
| Pfizer Investigational Site | Tampere | 33520 | Finland |
| Pfizer Investigational Site | Marseille | Cedex 05 | 13005 | France |
| Pfizer Investigational Site | Montpellier | Cedex 5 | 34295 | France |
| Pfizer Investigational Site | Lyon | Cedex | 69694 | France |
| Pfizer Investigational Site | Bayonne | 64109 | France |
| Pfizer Investigational Site | Bordeaux | 33076 | France |
| Pfizer Investigational Site | Grenoble | 38043 | France |
| Pfizer Investigational Site | Lille | 59037 | France |
| Pfizer Investigational Site | Marseille | 13009 | France |
| Pfizer Investigational Site | Nancy | 54000 | France |
| Pfizer Investigational Site | Nice | 06031 | France |
| Pfizer Investigational Site | Paris | 75013 | France |
| Pfizer Investigational Site | Paris | 75014 | France |
| Pfizer Investigational Site | Paris | 75019 | France |
| Pfizer Investigational Site | Rennes | 35033 | France |
| Pfizer Investigational Site | Strasbourg | 67091 | France |
| Pfizer Investigational Site | Toulouse | 31403 | France |
| Pfizer Investigational Site | Tours | 37044 | France |
| Pfizer Investigational Site | The Hague | South Holland | 2512 VA | Netherlands |
| Pfizer Investigational Site | Alkmaar | NL-1815 JD | Netherlands |
| Pfizer Investigational Site | Breda | Netherlands |
| Pfizer Investigational Site | Heeze | 5591 VE | Netherlands |
| Pfizer Investigational Site | Hilversum | NL-1213 XZ | Netherlands |
| Pfizer Investigational Site | Oss | 5342 BT | Netherlands |
| Pfizer Investigational Site | Southwest Heemstede | 2103 | Netherlands |
| Pfizer Investigational Site | Katowice | 40-635 | Poland |
| Pfizer Investigational Site | Krakow | 31-523 | Poland |
| Pfizer Investigational Site | Lublin | 27-718 | Poland |
| Pfizer Investigational Site | Warsaw | 00-416 | Poland |
| Pfizer Investigational Site | Warsaw | 02-097 | Poland |
| Pfizer Investigational Site | Warsaw | 02-957 | Poland |
| Pfizer Investigational Site | Wroclaw | 50-420 | Poland |
| Pfizer Investigational Site | Braga | 4701-965 | Portugal |
| Pfizer Investigational Site | Funchal | 9000-168 | Portugal |
| Pfizer Investigational Site | Lisbon | 1169-050 | Portugal |
| Pfizer Investigational Site | Matosinhos Municipality | 4454-509 | Portugal |
| Pfizer Investigational Site | Ponta Delgada | 9500-370 | Portugal |
| Pfizer Investigational Site | Porto | 4099-001 | Portugal |
| Pfizer Investigational Site | Lausanne | CH-1011 | Switzerland |
| Pfizer Investigational Site | Zurich | 8008 | Switzerland |
| Pfizer Investigational Site | Zurich | 8091 | Switzerland |
| Pfizer Investigational Site | Cambridge | Cambs | CB2 2QQ | United Kingdom |
| Pfizer Investigational Site | Truro | Cornwall | TR1 3LJ | United Kingdom |
| Pfizer Investigational Site | Plymouth | Devon | PL6 8DH | United Kingdom |
| Pfizer Investigational Site | Glasgow | G11 6NT | United Kingdom |
| Pfizer Investigational Site | Oxford | OX2 6HE | United Kingdom |
| Pfizer Investigational Site |
| ID | Term |
|---|---|
| D012640 | Seizures |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069583 | Pregabalin |
| ID | Term |
|---|---|
| D005680 | gamma-Aminobutyric Acid |
| D000613 | Aminobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided